Beattie, Mary S
Genentech
2 papers on CoChat
Most cited papers
- Verified
Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study
Meric-Bernstam, F., Hurwitz, H., Raghav, K. P. S., McWilliams, R. R., Fakih, M., VanderWalde, A., Swanton, C., Kurzrock, R., Burris, H., Sweeney, C., et al. (2019) · The Lancet Oncology
Colorectal Cancer Treatments and StudiesHER2/EGFR in Cancer Research
Cited by 573
- Verified
Targeted therapy for advanced solid tumors on the basis of molecular profiles: Results from MyPathway, an open-label, phase IIa multiple basket study
Hainsworth, J. D., Meric-Bernstam, F., Swanton, C., Hurwitz, H., Spigel, D. R., Sweeney, C., Burris, H. A., Bose, R., Yoo, B., Stein, A., et al. (2018) · Journal of Clinical Oncology
Lung Cancer Treatments and MutationsCancer Genomics and Diagnostics
Cited by 506
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free